Karyopharm Therapeutics (KPTI) FCF Margin (QoQ) (2013 - 2025)
Karyopharm Therapeutics (KPTI) FCF Margin (QoQ) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Karyopharm Therapeutics |
95.31 Mn |
31.56 Mn |
32.74 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
-2,140.00 |
| Sep 30, 2025 |
3,599.00 |
| Jun 30, 2025 |
8,059.00 |
| Mar 31, 2025 |
-4,555.00 |
| Dec 31, 2024 |
-3,417.00 |
| Sep 30, 2024 |
3,982.00 |
| Jun 30, 2024 |
4,261.00 |
| Mar 31, 2024 |
-7,751.00 |
| Dec 31, 2023 |
2,694.00 |
| Sep 30, 2023 |
-1,362.00 |
| Jun 30, 2023 |
-1,952.00 |
| Mar 31, 2023 |
3,107.00 |
| Dec 31, 2022 |
-134.00 |
| Sep 30, 2022 |
997.00 |
| Jun 30, 2022 |
3,578.00 |
| Mar 31, 2022 |
-14,436.00 |
| Dec 31, 2021 |
8,358.00 |
| Sep 30, 2021 |
18,309.00 |
| Jun 30, 2021 |
-1,928.00 |
| Mar 31, 2021 |
-13,976.00 |
